Infinifluidics Inc.

Infinifluidics Inc. is a for-profit corporate entity located in Philadelphia, Pennsylvania, specializing in advanced microfluidic technology for biomedical applications. Registered in SAM.gov since October 2020, the company focuses on developing innovative microfluidic chip technologies that enable precise manufacturing and scaling of complex biomedical systems, particularly in the realm of drug delivery and therapeutic development. The company appears to be a technology-driven enterprise that leverages semiconductor-like fabrication techniques to create sophisticated microfluidic platforms for pharmaceutical and biotechnological research.

Through federal grant awards, Infinifluidics Inc. has demonstrated significant expertise in developing advanced microfluidic technologies for drug delivery systems, with notable projects funded by the National Institute of General Medical Sciences and the National Science Foundation's Division of Industrial Innovation. Their primary grant work has centered on developing a Very Large-Scale Microfluidic Integration (VLSMI) chip for producing lipid nanoparticles (LNPs) for RNA therapeutics and vaccines, with a specific focus on scalable manufacturing processes. The company has received grants totaling at least $256,000, working on projects that enable on-demand continuous and sterile manufacturing of injectable drug delivery systems. A recent sub-award from the University of Pennsylvania involves collaborative research to develop an automated high-throughput formulation screening platform, with the company contributing expertise in microfluidics, semiconductor fabrication, and robotic product integration. Their work spans critical areas such as developing precise LNP production methods, exploring formulation strategies for RNA therapeutics, and creating scalable manufacturing technologies that can support various phases of drug development.